Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Treatment of Juvenile Myelomonocytic Leukemia
Christina Mayerhofer, Charlotte M. Niemeyer, Christian Flotho
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3084-3084
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia
Martina Rudelius, Olga K. Weinberg, Charlotte M. Niemeyer, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 113-130
Closed Access | Times Cited: 43
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies
Melissa R. Perrino, Anirban Das, Sarah Scollon, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 21, pp. 4834-4843
Closed Access | Times Cited: 7
The therapeutic potential of neurofibromin signaling pathways and binding partners
Juan Báez-Flores, Mario Rodríguez-Martín, Jesús Lacal
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 15
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Déborah Meyran, Chloé Arfeuille, Sylvie Chevret, et al.
Haematologica (2024)
Open Access | Times Cited: 5
Noonan syndrome
Michael A. Patton
Elsevier eBooks (2025)
Closed Access
A novel conditioning regimen involving haploid immune cell infusion combined with umbilical cord blood transplantation for the treatment of juvenile myelomonocytic leukemia
Tianqi Liang, Chunfu Li, Yun Chen, et al.
European Journal of Pediatrics (2025) Vol. 184, Iss. 5
Closed Access
Managing Juvenile Myelomonocytic Leukemia in Resource-Constraint Setting: New Hope with Isotretinoin-based Cytoreductive Therapy
Eshita Reza Khan, Ferdousi Begum, Sabina Karim
Haematology Journal of Bangladesh (2025) Vol. 9, Iss. 1, pp. 30-32
Open Access
Recommendations on the Organization of Care for Bulgarian Patients with RASopathies, Adopted Within the Framework of The RASopathies – Unknown Problems and Future Perspectives International Scientific Meeting
Yana Deyanova, Todor Ruskov, Yuliya Bazdarska, et al.
Scripta Scientifica Medica (2025) Vol. 57, Iss. 1, pp. 27-36
Open Access
Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study
Zhiyong Peng, Jingyu Gao, Litao Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia
Chunxiao He, Zhiyong Peng, Dengyang Zhang, et al.
Biochemical Pharmacology (2023) Vol. 213, pp. 115588-115588
Open Access | Times Cited: 5
Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging
Suzanne M. Watt, Hua Peng, Irene Roberts
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3675-3675
Open Access | Times Cited: 9
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
Elliot Stieglitz, Christine Gu, Michelle Richardson, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 3
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia
Jiapei Gao, Shuai Han, Bin Deng, et al.
Annals of Hematology (2023) Vol. 103, Iss. 8, pp. 2591-2600
Closed Access | Times Cited: 3
Identification of Germinal Neurofibromin Hotspots
Sergio Lois, Juan Báez-Flores, María Isidoro‐García, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2044-2044
Open Access | Times Cited: 4
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia
Cristina Bugarin, Laura Antolini, Chiara Buracchi, et al.
Haematologica (2023) Vol. 109, Iss. 2, pp. 521-532
Open Access | Times Cited: 2
Unusual Presentation of SET::NUP214-Associated Concomitant Hematological Neoplasm in a Child—Diagnostic and Treatment Struggle
Yaroslav Menchits, T. Yu. Salimova, Alexander Komkov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14451-14451
Open Access | Times Cited: 2
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Ying Wu, Patricia M. A. Zehnle, Jovana Rajak, et al.
Leukemia (2023) Vol. 38, Iss. 1, pp. 136-148
Open Access | Times Cited: 2
Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group
Eun Sang Yi, Hee Jo Baek, Hee Young Ju, et al.
Leukemia Research (2023) Vol. 129, pp. 107070-107070
Closed Access | Times Cited: 1
Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape
Roshani Sinha, Mai Dvorak, Ananthakrishnan Ganesan, et al.
(2023)
Open Access | Times Cited: 1
Myeloproliferative Disorders in Non-Down Syndrome Patients
Bianca F. Goemans, Jessica A. Pollard
Pediatric oncology (2024), pp. 177-191
Closed Access
Prediction of SHP2-E76K binding sites based on molecular dynamics simulation and Markov algorithm
Sipei Zhang, Lijuan Chen, Zhenliang Shi, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access
Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults
Aleksandra Ozygała, Joanna Rokosz-Mierzwa, Paulina Widz, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4114-4114
Open Access
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia
Sha Fu, Yao Guo, Zhiyong Peng, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Open Access
Immunophenotypic changes in juvenile myelomonocytic leukaemia after treatment with hypomethylating agent: Do they help to evaluate dept of response?
Anita Frisanco Oliveira, Aline Tansini, Thaís Regina Toledo, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 3, pp. 339-348
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top